The effect of gliclazide and glibenclamide on preconditioning of the human myocardium

European Journal of Pharmacology

Volumn 515, Issue 1-3, 2005, Pages 142-149

  Loubani, Mahmoud ^a   Fowler, Alan ^a   Standen, Nicholas B ^a   Galiñanes, Manuel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Glibenclamide; Gliclazide; Human myocardium; Preconditioning

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM CHANNEL; PROTEIN KINASE C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HEART INFARCTION PREVENTION; HEART PROTECTION; HEART RIGHT ATRIUM; HEART SURGERY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURGICAL PATIENT; TIME;

ALGORITHMS; ATRIAL APPENDAGE; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLICLAZIDE; GLYBURIDE; HEART; HUMANS; HYPOGLYCEMIC AGENTS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POTASSIUM CHANNELS; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 20344406483     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.002     Document Type: Article

References (35)

1. ATP channels Physiol. Rev. 78 1998 227 245
2. F.M. Ashcroft, and P. Rorsman Electrophysiology of the pancreatic beta-cell Prog. Biophys. Mol. Biol. 54 1989 87 143
3. P.A. Brady, and A. Terzic The sulphonylurea controversy: more questions from the heart J. Am. Coll. Cardiol. 31 1998 950 956
4. D.B. Campbell, R. Lavielle, and C. Nathan The mode of action and clinical pharmacology of gliclazide: a review Diabetes Res. Clin. Pract. 14 Suppl. 2 1991 S21 S36
5. ATP channel Annu. Rev. Physiol. 62 2000 79 109
6. N. D'hahan, C. Moreau, A.L. Prost, H. Jacquet, A.E. Alekseev, A. Terzic, and M. Vivaudou Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP Proc. Natl. Acad. Sci. U. S. A. 96 1999 12162 12167
7. R. Fietsam Jr., J. Bassett, and J.L. Glover Complications of coronary artery surgery in diabetic patients Ann. Surg. 57 1991 551 557
8. + channels. Possible mechanism of cardioprotection Circ. Res. 81 1997 1072 1082
9. S. Ghosh, N.B. Standen, and M. Galiñanes Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection Cardiovasc. Res. 45 2000 339 350
10. ATP channels as effectors of human myocardial preconditioning Cardiovasc. Res. 45 2000 934 940
11. S. Ghosh, N.B. Standen, and M. Galiñanes Failure to precondition pathological human myocardium J. Am. Coll. Cardiol. 37 2001 711 718
12. ATP channels to gliclazide Diabetologia 42 1999 845 848
13. ATP channels Diabetes 47 1998 1412 1418
14. G.J. Gross, and J.A. Auchampach Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs Circ. Res. 70 1992 223 233
15. + channels and myocardial preconditioning Circ. Res. 84 1999 973 979
16. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart J. Physiol. 542 2002 735 741
17. + channels Neuron 16 1996 1011 1017
18. A. Klamann, P. Sarfert, V. Launhardt, G. Schulte, W.H. Schmiegel, and M.A. Nauck Myocardial infarction in diabetic vs. non-diabetic subjects. Survival and infarct size following therapy with sulphonylureas (glibenclamide) Eur. Heart J. 21 2000 220 229
19. H. Klepzig, G. Kober, C. Matter, H. Luus, H. Schneider, K.H. Boedeker, W. Kiowski, F.W. Amann, D. Gruber, S. Harris, and W. Burger Sulphonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide Eur. Heart J. 20 1999 439 446
20. ATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells Diabetologia 44 2001 1019 1025
21. ATP channels are upstream and p38MAPK is downstream of PKC BMC Physiol. 2 2002 10
22. T. Maeda, T. Yamaguchi, and M. Hashimoto Gas chromatographic determination of the hypoglycaemic agent gliclazide in plasma J. Chromatogr. 223 1981 357 363
23. A. Matsuda, T. Kuzuya, Y. Sugita, and K. Kawashima Plasma levels of glibenclamide in diabetic patients during its routine clinical administration by a specific radioimmunoassay Horm. Metab. Res. 15 1983 425 428
24. M.B. Mitchell, X. Meng, L. Ao, J.M. Brown, A.H. Harken, and A. Banerjee Preconditioning of isolated rat heart is mediated by protein kinase C Circ. Res. 76 1995 73 81
25. M.M. Mocanu, H.L. Maddock, G.F. Baxter, C.L. Lawrence, N.B. Standen, and D.M. Yellon Glimepiride, a novel sulphonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide Circulation 103 2001 3111 3116
26. T. Oida, K. Yoshida, A. Kagemoto, Y. Sekine, and T. Higashijima The metabolism of gliclazide in man Xenobiotica 15 1985 87 96
27. ATP channels triggers the preconditioned state by generating free radicals Circ. Res. 87 2000 460 466
28. K.J. Palmer, and R.N. Brogden Gliclazide: an update of its pharmacological properties and therapeutic efficiency in non-insulin-dependent diabetes mellitus Drugs 46 1993 92 125
29. + channels by taurine through a benzamido-binding site on sulfonylurea receptor 1 Biochem. Pharmacol. 67 2004 1089 1096
30. H. Singh, D. Hudman, C.L. Lawrence, R.D. Rainbow, D. Lodwick, and R.I. Norman Distribution of Kir6.x and SUR2 ATP-sensitive potassium channel subunits in isolated ventricular myocytes J. Mol. Cell. Cardiol. 45 2003 445 459
31. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model Circ. Res. 77 1995 1030 1035
32. University Group Diabetes Program A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes: VI. Supplementary report on nonfatal events in patients treated with tolbutamide Diabetes 25 1976 1129 1153
33. + channel for cardiac protection against ischemic injury is dependent on protein kinase C activity Circ. Res. 85 1999 731 741
34. W.B. Wan Mohamad, A. Tun Fizi, R.B. Ismail, and M. Mafauzy Efficacy and safety of single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus Diabetes Res. Clin. Pract. 49 2000 93 99
35. J.G. Zhang, S. Ghosh, C.D. Ockleford, and M. Galiñanes Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man Clin. Sci. 99 2000 443 453